Literature DB >> 1374905

Evidence that Mos protein may not act directly on cyclin.

W Xu1, K J Ladner, L D Smith.   

Abstract

Using affinity-purified antiserum we have examined cyclin B2 levels in Xenopus oocytes at various stages of oogenesis. We found that cyclin B2 is detected from stage 2 to stage 6 as two bands, one of which is phosphorylated, and that cyclin B2 mass increases about 28-fold between stage 2 and stage 6. To examine the effect of Mos protein on cyclin phosphorylation, we microinjected synthetic Xenopus c-mos (c-mosxe) RNA into stages 4, 5, and 6 Xenopus oocytes. In stage 6 oocytes, maturation was induced by c-mosxe RNA, and, as is the case with progesterone treatment, all cyclin B2 was shifted to the phosphorylated form. However, c-mosxe RNA injected into stage 4 or 5 oocytes did not induce maturation or cause a shift in the relative proportion of the two cyclin B2 bands. These data suggest that Mos does not act directly to phosphorylate cyclin B2, causing the band shift during maturation. Cyclin B2 synthesis increases about 2-fold during maturation, in concert with total protein synthesis. Data from experiments on cyclin B2 stability indicate that the half-life of cyclin B2 is about 85 hr in stage 6. This suggests that if Mos protein has a direct effect on cyclin stability, it does so only at a later stage in oocyte maturation, but not at the onset.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1374905      PMCID: PMC49125          DOI: 10.1073/pnas.89.10.4573

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  Effects of cyclohexamide on a cytoplasmic factor initiating meiotic naturation in Xenopus oocytes.

Authors:  W J Wasserman; Y Masui
Journal:  Exp Cell Res       Date:  1975-03-15       Impact factor: 3.905

2.  Phosphorylation of Xenopus cyclins B1 and B2 is not required for cell cycle transitions.

Authors:  T Izumi; J L Maller
Journal:  Mol Cell Biol       Date:  1991-08       Impact factor: 4.272

3.  Protein incorporation by isolated amphibian oocytes. 3. Optimum incubation conditions.

Authors:  R A Wallace; D W Jared; J N Dumont; M W Sega
Journal:  J Exp Zool       Date:  1973-06

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  The mechanism for increased protein synthesis during Xenopus oocyte maturation.

Authors:  J D Richter; W J Wasserman; L D Smith
Journal:  Dev Biol       Date:  1982-01       Impact factor: 3.582

Review 6.  Xenopus oocytes and the biochemistry of cell division.

Authors:  J L Maller
Journal:  Biochemistry       Date:  1990-04-03       Impact factor: 3.162

7.  Meiotic induction by Xenopus cyclin B is accelerated by coexpression with mosXe.

Authors:  R S Freeman; S M Ballantyne; D J Donoghue
Journal:  Mol Cell Biol       Date:  1991-03       Impact factor: 4.272

8.  In vivo regulation of MPF in Xenopus oocytes.

Authors:  A D Johnson; L D Smith
Journal:  Development       Date:  1990-05       Impact factor: 6.868

9.  On the synthesis and destruction of A- and B-type cyclins during oogenesis and meiotic maturation in Xenopus laevis.

Authors:  H Kobayashi; J Minshull; C Ford; R Golsteyn; R Poon; T Hunt
Journal:  J Cell Biol       Date:  1991-08       Impact factor: 10.539

10.  Cell cycle dynamics of an M-phase-specific cytoplasmic factor in Xenopus laevis oocytes and eggs.

Authors:  J Gerhart; M Wu; M Kirschner
Journal:  J Cell Biol       Date:  1984-04       Impact factor: 10.539

View more
  2 in total

1.  The c-mos proto-oncogene protein kinase turns on and maintains the activity of MAP kinase, but not MPF, in cell-free extracts of Xenopus oocytes and eggs.

Authors:  A R Nebreda; T Hunt
Journal:  EMBO J       Date:  1993-05       Impact factor: 11.598

2.  The metaphase II arrest in mouse oocytes is controlled through microtubule-dependent destruction of cyclin B in the presence of CSF.

Authors:  J Z Kubiak; M Weber; H de Pennart; N J Winston; B Maro
Journal:  EMBO J       Date:  1993-10       Impact factor: 11.598

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.